Stock Earnings

Question 1

Quels sont les états financiers clés de Black Diamond Therapeutics Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Black Diamond Therapeutics Inc a un total d'actifs de $123, un bénéfice net loss de $-70

Question 2

Quels sont les ratios financiers clés pour BDTX ?

Accepted Answer

Le ratio de liquidité de Black Diamond Therapeutics Inc est 3.15, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de Black Diamond Therapeutics Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Black Diamond Therapeutics Inc data is not available.

Question 4

Black Diamond Therapeutics Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Black Diamond Therapeutics Inc a un bénéfice net loss de $-70

Question 5

Black Diamond Therapeutics Inc a-t-elle des passifs ?

Accepted Answer

yes, Black Diamond Therapeutics Inc a un passif de 39

Question 6

Combien d'actions en circulation Black Diamond Therapeutics Inc a-t-elle ?

Accepted Answer

Black Diamond Therapeutics Inc a un total d'actions en circulation de 57

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	70	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	18	27	27	28	30	21
Research & Development	39	51	59	64	96	48
Operating Expenses	57	79	86	92	126	69
Other Non Operating Income (Expenses)	6	6	2	0	-2	-1
Pretax Income	21	-70	-82	-91	-125	-67
Income Tax Expense	--	0	--	--	--	--
Net Income	21	-70	-82	-91	-125	-67
Net Income Growth	-129%	-15%	-10%	-27%	87%	91%
Shares Outstanding (Diluted)	56.92	55	44	36.33	36.19	32.91
Shares Change (YoY)	0%	25%	21%	0%	10%	1%
EPS (Diluted)	0.36	-1.27	-1.88	-2.51	-3.47	-2.04
EPS Growth	-128%	-32%	-25%	-28%	70%	89%
Free Cash Flow	21	-62	-67	-85	-102	-52
Free Cash Flow Per Share	0.36	-1.12	-1.52	-2.33	-2.81	-1.58
Gross Margin	--	--	--	--	--	--
Operating Margin	17.14%	0%	0%	0%	0%	0%
Profit Margin	30%	0%	0%	0%	0%	0%
Free Cash Flow Margin	30%	0%	0%	0%	0%	0%
EBITDA	12	-79	-86	-92	-126	-69
EBITDA Margin	17.14%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	12	-79	-86	-92	-126	-69
EBIT Margin	17.14%	0%	0%	0%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Black Diamond Therapeutics Inc (BDTX) Price